Butler John P.
- SEC CIK
- 0001591467
In the past year, 1 open-market purchase filing worth $86.6K and 1 sale filing worth $474.4K.
Current role at each company
- AKBA Akebia Therapeutics, Inc.CEO and Presidentas of Aug 10, 2026
- ZYNE Zynerba Pharmaceuticals, Inc.Directoras of Oct 11, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $86.6K
- 1 filing
- Sold
- $474.4K
- 1 filing
- Net
- −$387.8K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Butler John P. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AKBA Akebia Therapeutics, Inc.
CEO and President10 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2026 (view filing) | Mar 4 | 1 day | Butler John P.CEO and President | PPurchase | +69.3K | $1.25 | +$86.6K | +2.1%3.37M after | |
| Feb 4, 2026 (view filing) | Feb 2 | 2 days | Butler John P.CEO and President | SSale | −341.3K | $1.39 | −$474.4K | −9.4%3.30M after | 4 lots10b5-1 |
| Mar 4, 2025 (view filing) | Mar 3 | 1 day | Butler John P.CEO and President | SSale | −46.4K | $1.83 | −$84.9K | −1.8%2.56M after | 10b5-1 |
| Feb 4, 2025 (view filing) | Feb 3 | 1 day | Butler John P.CEO and President | SSale | −144.3K | $2.10 | −$302.9K | −5.2%2.60M after | 2 lots10b5-1 |
| Mar 1, 2024 (view filing) | Feb 29 | 1 day | Butler John P.CEO and President | SSale | −46.6K | $1.58 | −$73.6K | −2.2%2.04M after | |
| Feb 29, 2024 (view filing) | Feb 27 | 2 days | Butler John P.CEO and President | SSale | −37.7K | $1.52 | −$57.4K | −1.8%2.09M after | |
| Feb 2, 2024 (view filing) | Feb 1 | 1 day | Butler John P.CEO and President | SSale | −46.5K | $1.68 | −$78.1K | −2.1%2.13M after | |
| Mar 3, 2023 (view filing) | Mar 1 | 2 days | Butler John P.CEO and President | SSale | −91.9K | $0.88 | −$80.8K | −5.5%1.57M after | 3 lots |
| Mar 1, 2023 (view filing) | Feb 27 | 2 days | Butler John P.CEO and President | SSale | −38.6K | $0.81 | −$31.3K | −2.3%1.66M after | |
| Mar 2, 2022 (view filing) | Feb 28-Mar 1 | 2 days | Butler John P.CEO and President | SSale | −79.0K | $2.16 | −$171.0K | −5.3%1.40M after | 4 lots |
ZYNE Zynerba Pharmaceuticals, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2023 (view filing)4:28 PM ET | Jun 14 | 1 day | Butler John P.Director | SSale | −115 | $0.3481 | −$40.03 | −0.1%80.8K after | |
| Jun 16, 2022 (view filing) | Jun 14 | 2 days | Butler John P.Director | SSale | −53 | $1.01 | −$53.53 | −0.2%33.1K after |